Skip to main content

Special Aspects of Familial Mediterranean Fever in Childhood

  • Chapter
Familial Mediterranean Fever

Part of the book series: Rare Diseases of the Immune System ((RDIS,volume 3))

  • 1073 Accesses

Abstract

FMF is a disease, which usually manifests in early childhood: in 90 % of cases, first symptoms are present before the 20th year of life and in 75 % before the 10th year of life [1] (Table 3.1). Immediate postnatal manifestations are reported [2]. A late onset of disease, defined as manifestation after the 40th birthday, is rare and only be present in less the 1 % of patients [3]. In the large Turkish registry, the mean age of manifestation was 9.6 years, the mean age of diagnosis 16.4 years [4]. But the general awareness for the diseases as well as the better diagnostical tools improved the early diagnosis dramatically in the last decades [5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53.

    Article  CAS  PubMed  Google Scholar 

  2. Saatci U, et al. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr. 1997;156:619–23.

    Article  CAS  PubMed  Google Scholar 

  3. Tamir N, et al. Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics. Am J Med Genet. 1999;87:30–5.

    Article  CAS  PubMed  Google Scholar 

  4. Tunca M, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84:1–11.

    Article  Google Scholar 

  5. Toplak N, et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis. 2012;71:1177–82. doi:10.1136/annrheumdis-2011-200549.

    Article  PubMed  Google Scholar 

  6. Schwabe AD, Peters RS. Familial Mediterranean fever in Armenians. Analysis of 100 cases. Medicine (Baltimore). 1974;53:453–62.

    Article  CAS  Google Scholar 

  7. Gruber C, et al. History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatr Allergy Immunol. 2008;19:505–12. doi:10.1111/j.1399-3038.2007.00688.x.

    Article  PubMed  Google Scholar 

  8. Padeh S, et al. Familial Mediterranean fever in the first two years of life: a unique phenotype of disease in evolution. J Pediatr. 2010;156:985–9. doi:10.1016/j.jpeds.2009.12.010.

    Article  PubMed  Google Scholar 

  9. Padeh S, et al. Familial Mediterranean fever in children presenting with attacks of fever alone. J Rheumatol. 2010;37:865–9. doi:10.3899/jrheum.090687.

    Article  PubMed  Google Scholar 

  10. Hentgen V, Grateau G, Stankovic-Stojanovic K, Amselem S, Jeru I. Familial Mediterranean fever in heterozygotes: are we able to accurately diagnose the disease in very young children? Arthritis Rheum. 2013;65:1654–62. doi:10.1002/art.37935.

    Article  PubMed  Google Scholar 

  11. Samuels J, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore). 1998;77:268–97.

    Article  CAS  Google Scholar 

  12. Berkun Y, Ben-Chetrit E, Klar A. Peritoneal adhesions and intestinal obstructions in patients with familial Mediterranean fever–are they more frequent? Semin Arthritis Rheum. 2007;36:316–21. doi:10.1016/j.semarthrit.2006.11.002.

    Article  PubMed  Google Scholar 

  13. Brik R, et al. Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain. J Pediatr. 2001;138:759–62. doi:10.1067/mpd.2001.113357.

    Article  CAS  PubMed  Google Scholar 

  14. Majeed HA, Barakat M. Familial Mediterranean fever (recurrent hereditary polyserositis) in children: analysis of 88 cases. Eur J Pediatr. 1989;148:636–41.

    Article  CAS  PubMed  Google Scholar 

  15. Majeed HA, Rawashdeh M. The clinical patterns of arthritis in children with familial Mediterranean fever. QJM. 1997;90:37–43.

    Article  CAS  PubMed  Google Scholar 

  16. Garcia-Gonzalez A, Weisman MH. The arthritis of familial Mediterranean fever. Semin Arthritis Rheum. 1992;22:139–50.

    Article  CAS  PubMed  Google Scholar 

  17. Kaushansky K, Finerman GA, Schwabe AD. Chronic destructive arthritis in familial Mediterranean fever: the predominance of hip involvement and its management. Clin Orthop Relat Res. 1981;155:156–61.

    PubMed  Google Scholar 

  18. Sneh E, Pras M, Michaeli D, Shanin N, Gafni J. Protracted arthritis in familial Mediterranean fever. Rheumatol Rehabil. 1977;16:102–6.

    Article  CAS  PubMed  Google Scholar 

  19. Kasifoglu T, Calisir C, Cansu DU, Korkmaz C. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. 2009;28:41–6. doi:10.1007/s10067-008-0980-3.

    Article  PubMed  Google Scholar 

  20. Zemer D, Cabili S, Revach M, Shahin N. Constrictive pericarditis in familial Mediterranean fever. Isr J Med Sci. 1977;13:55–8.

    CAS  PubMed  Google Scholar 

  21. Kees S, et al. Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). QJM. 1997;90:643–7.

    Article  CAS  PubMed  Google Scholar 

  22. Tutar HE, et al. The changing aetiological spectrum of pericarditis in children. Ann Trop Paediatr. 2002;22:251–6. doi:10.1179/027249302125001534.

    Article  PubMed  Google Scholar 

  23. Tutar HE, et al. Isolated recurrent pericarditis in a patient with familial Mediterranean fever. Eur J Pediatr. 2001;160:264–5.

    Article  CAS  PubMed  Google Scholar 

  24. Salah S, Hegazy R, Ammar R, Sheba H, Abdelrahman L. MEFV gene mutations and cardiac phenotype in children with familial Mediterranean fever: a cohort study. Pediatr Rheumatol Online J. 2014;12:5. doi:10.1186/1546-0096-12-5.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Lidar M, et al. Erysipelas-like erythema as the presenting feature of familial Mediterranean fever. J Eur Acad Dermatol Venereol. 2013;27:912–5. doi:10.1111/j.1468-3083.2011.04442.x.

    Article  CAS  PubMed  Google Scholar 

  26. Pras E, et al. Clinical differences between north African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 1998;75:216–9.

    Article  CAS  PubMed  Google Scholar 

  27. Cefle A, et al. A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis. Rheumatol Int. 2005;25:442–6. doi:10.1007/s00296-004-0471-z.

    Article  PubMed  Google Scholar 

  28. Delibas A, et al. Genetic risk factors of amyloidogenesis in familial Mediterranean fever. Am J Nephrol. 2005;25:434–40. doi:10.1159/000087824.

    Article  CAS  PubMed  Google Scholar 

  29. Kone Paut I, et al. Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology (Oxford). 2000;39:1275–9.

    Article  CAS  Google Scholar 

  30. Shinar Y, et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol. 2000;27:1703–7.

    CAS  PubMed  Google Scholar 

  31. Turkcapar N, et al. The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. Rheumatol Int. 2007;27:545–51. doi:10.1007/s00296-006-0255-8.

    Article  CAS  PubMed  Google Scholar 

  32. Majeed HA, Quabazard Z, Hijazi Z, Farwana S, Harshani F. The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study. Q J Med. 1990;75:607–16.

    CAS  PubMed  Google Scholar 

  33. Majeed HA, Ghandour K, Shahin HM. The acute scrotum in Arab children with familial Mediterranean fever. Pediatr Surg Int. 2000;16:72–4.

    Article  CAS  PubMed  Google Scholar 

  34. Eshel G, Vinograd I, Barr J, Zemer D. Acute scrotal pain complicating familial Mediterranean fever in children. Br J Surg. 1994;81:894–6.

    Article  CAS  PubMed  Google Scholar 

  35. Gedalia A, Mordehai J, Mares AJ. Acute scrotal involvement in children with familial Mediterranean fever. Am J Dis Child. 1992;146:1419–20.

    CAS  PubMed  Google Scholar 

  36. Ertekin V, Selimoglu MA, Alp H, Yilmaz N. Familial Mediterranean fever protracted febrile myalgia in children: report of two cases. Rheumatol Int. 2005;25:398–400. doi:10.1007/s00296-004-0535-0.

    Article  PubMed  Google Scholar 

  37. Brik R, Shinawi M, Kasinetz L, Gershoni-Baruch R. The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum. 2001;44:1416–9. doi:10.1002/1529-0131(200106)44:6<1416::AID-ART236>3.0.CO;2-6.

    Article  CAS  PubMed  Google Scholar 

  38. Zemer D, et al. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314:1001–5. doi:10.1056/NEJM198604173141601.

    Article  CAS  PubMed  Google Scholar 

  39. Ozen S, et al. Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis. 2013. doi:10.1136/annrheumdis-2012-202708.

    Google Scholar 

  40. Gedalia A, Zamir S. Neurologic manifestations in familial Mediterranean fever. Pediatr Neurol. 1993;9:301–2.

    Article  CAS  PubMed  Google Scholar 

  41. Akman-Demir G, et al. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? J Neurol. 2006;253:928–34. doi:10.1007/s00415-006-0137-8.

    Article  CAS  PubMed  Google Scholar 

  42. Unal A, Dursun A, Emre U, Tascilar NF, Ankarali H. Evaluation of common mutations in the Mediterranean fever gene in multiple sclerosis patients: is it a susceptibility gene? J Neurol Sci. 2010;294:38–42. doi:10.1016/j.jns.2010.04.008.

    Article  CAS  PubMed  Google Scholar 

  43. Kalyoncu U, et al. Familial Mediterranean fever and central nervous system involvement: a case series. Medicine (Baltimore). 2010;89:75–84. doi:10.1097/MD.0b013e3181d5dca7.

    Article  Google Scholar 

  44. Capron J, Grateau G, Steichen O. Is recurrent aseptic meningitis a manifestation of familial Mediterranean fever? A systematic review. Clin Exp Rheumatol. 2013;31:127–32.

    PubMed  Google Scholar 

  45. Ozdogan H, et al. Vasculitis in familial Mediterranean fever. J Rheumatol. 1997;24:323–7.

    CAS  PubMed  Google Scholar 

  46. Ozcakar ZB, et al. MEFV mutations modify the clinical presentation of Henoch-Schonlein purpura. J Rheumatol. 2008;35:2427–9.

    Article  PubMed  Google Scholar 

  47. Ozen S, et al. Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum. 2001;30:281–7. doi:10.1053/sarh.2001.19958.

    Article  CAS  PubMed  Google Scholar 

  48. Hull KM, Shoham N, Chae JJ, et al. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol. 2003;15:61–9.

    Article  CAS  PubMed  Google Scholar 

  49. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351:659–64.

    Article  CAS  PubMed  Google Scholar 

  50. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–85.

    Article  CAS  PubMed  Google Scholar 

  51. Yalcınkaya F, Ozen S, Ozcakar B, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology. 2009;48:395–8.

    Article  PubMed  Google Scholar 

  52. Kondi A, Hentgen V, Piram M, Letierce A, Guillaume-Czitrom S, Koné-Paut I. Validation of the new paediatric criteria for the diagnosis of familial Mediterranean fever: data from a mixed population of 100 children from the French reference centre for auto-inflammatory disorders. Rheumatology (Oxford). 2010;49:2200–3.

    Article  Google Scholar 

  53. Consortium TFF. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25–31.

    Article  Google Scholar 

  54. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997;90:797–807.

    Google Scholar 

  55. Berkun Y, Ben-Chetrit E. Pyrin and cryopyrin–similar domain sequence but opposite inflammatory consequence. Clin Exp Rheumatol. 2007;25:S6–8.

    CAS  PubMed  Google Scholar 

  56. Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol. 2014;10:135–47.

    Article  CAS  PubMed  Google Scholar 

  57. Shinar Y, Obici L, Aksentijevich I, et al. Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis. 2012;71:1599–605.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  58. Ozen S. Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation? Arthritis Rheum. 2009;60(6):1575–7.

    Article  CAS  PubMed  Google Scholar 

  59. Ozaltin F, Bilginer Y, Gülhan B, et al. Diagnostic validity of colchicine in patients with familial Mediterranean fever. Clin Rheumatol. 2014;33:969–74.

    Article  PubMed  Google Scholar 

  60. Zemer D, Revach M, Pras M, et al. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med. 1974;291:932–4.

    Article  CAS  PubMed  Google Scholar 

  61. Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med. 1972;287:1302.

    CAS  PubMed  Google Scholar 

  62. Ozkan E, Okur O, Ekmekci A, Ozcan R, Tag T. A new approach to the treatment of periodic fever. Med Bull İstanbul. 1972;5:44–9.

    Google Scholar 

  63. Tateishi T, Soucek P, Caraco Y, Guengerich FP, Wood AJ. Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation. Biochem Pharmacol. 1997;53(1):111–6.

    Google Scholar 

  64. Kallinich T, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus treatment. Pediatrics. 2007;119:474–83.

    Article  Google Scholar 

  65. Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum. 1998;28:48–59.

    Article  CAS  PubMed  Google Scholar 

  66. Ozen S, Demirkaya E, Duzova A, et al. FMF50: a score for assessing outcome in familial Mediterranean fever. Ann Rheum Dis. 2014;73:897–901.

    Article  PubMed  Google Scholar 

  67. Calligaris L, Marchetti F, Tommasini A, Ventura A. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. Eur J Pediatr. 2008;167:695–6.

    Article  PubMed Central  PubMed  Google Scholar 

  68. Kuijk LM, Govers AM, Frenkel J, Hofhuis WJ. Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra. Ann Rheum Dis. 2007;66:1545–6.

    Article  PubMed Central  PubMed  Google Scholar 

  69. Mitroulis I, Papadopoulos VP, Konstantinidis T, Ritis K. Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient. Neth J Med. 2008;66:489–91.

    CAS  PubMed  Google Scholar 

  70. Ozen S, Bilginer Y, Aktay Ayaz N, Calguneri M. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine. J Rheumatol. 2011;38:516–8.

    Article  PubMed  Google Scholar 

  71. Hacihamdioglu DO, Ozen S. Canakinumab induces remission in a patient with resistant familial Mediterranean fever. Rheumatology (Oxford). 2012;51:1041.

    Article  CAS  Google Scholar 

  72. Mitroulis I, Skendros P, Oikonomou A, Tzioufas AG, Ritis K. The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis. Ann Rheum Dis. 2011;70:1347–8.

    Article  PubMed  Google Scholar 

  73. Hashkes PJ, Spalding SJ, Giannini EH, et al. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med. 2012;157:533–41.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tilmann Kallinich .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kallinich, T., Aktay, N., Ozen, S. (2015). Special Aspects of Familial Mediterranean Fever in Childhood. In: Gattorno, M. (eds) Familial Mediterranean Fever. Rare Diseases of the Immune System, vol 3. Springer, Cham. https://doi.org/10.1007/978-3-319-14615-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14615-7_3

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14614-0

  • Online ISBN: 978-3-319-14615-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics